National Health (Pharmaceutical Benefits Early Supply) Amendment Instrument 2014 (No. 9) – specification under subsection 84AAA(2) (No. PB 106 of 2014) (Cth)

PB 106 of 2014

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 9) – specification under subsection 84AAA(2)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated    19 December 2014

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 9) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 106 of 2014.

2          Commencement

This Instrument commences on 1 January 2015.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, after entry for Dutasteride with Tamsulosin

insert:

Empagliflozin	Tablet 10 mg	Oral	30	5
Tablet 25 mg	Oral	30	5

1. Schedule 1, after entry for Ezetimibe

insert:

Ezetemibe and rosuvastatin	Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)	Oral	1	5
	Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)	Oral	1	5
	Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)	Oral	1	5
	Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)	Oral	1	5